Business
Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent – ABC News
Pfizer will ask regulators for the pill to be made available for global use as soon as possible after clinical trials suggested…
Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:
- Pfizer says preliminary…
Continue Reading
-
Business19 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News19 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business19 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Business21 hours agoThis ASX All Ords stock has more than doubled investor’s money since January. Here’s why it’s tipped to surge another 45%!